Literature DB >> 17478730

MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.

Ruirui Ji1, Yunhui Cheng, Junming Yue, Jian Yang, Xiaojun Liu, He Chen, David B Dean, Chunxiang Zhang.   

Abstract

MicroRNAs (miRNAs) are a recently discovered class of endogenous, small, noncoding RNAs that regulate about 30% of the encoding genes of the human genome. However, the role of miRNAs in vascular disease is currently completely unknown. Using microarray analysis, we demonstrated for the first time that miRNAs are aberrantly expressed in the vascular walls after balloon injury. The aberrantly expressed miRNAs were further confirmed by Northern blot and quantitative real-time polymerase chain reaction. Modulating an aberrantly overexpressed miRNA, miR-21, via antisense-mediated depletion (knock-down) had a significant negative effect on neointimal lesion formation. In vitro, the expression level of miR-21 in dedifferentiated vascular smooth muscle cells was significantly higher than that in fresh isolated differentiated cells. Depletion of miR-21 resulted in decreased cell proliferation and increased cell apoptosis in a dose-dependent manner. MiR-21-mediated cellular effects were further confirmed in vivo in balloon-injured rat carotid arteries. Western blot analysis demonstrated that PTEN and Bcl-2 were involved in miR-21-mediated cellular effects. The results suggest that miRNAs are novel regulatory RNAs for neointimal lesion formation. MiRNAs may be a new therapeutic target for proliferative vascular diseases such as atherosclerosis, postangioplasty restenosis, transplantation arteriopathy, and stroke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478730     DOI: 10.1161/CIRCRESAHA.106.141986

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  389 in total

1.  Circulating and renal vein levels of microRNAs in patients with renal artery stenosis.

Authors:  Moo Yong Park; Sandra M Herrmann; Ahmed Saad; Robert Jay Widmer; Hui Tang; Xiang-Yang Zhu; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2014-10-31       Impact factor: 5.992

2.  MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation.

Authors:  Jing Zhou; Kuei-Chun Wang; Wei Wu; Shankar Subramaniam; John Y-J Shyy; Jeng-Jiann Chiu; Julie Y-S Li; Shu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-02       Impact factor: 11.205

Review 3.  MicroRNA expression and function in cardiac ischemic injury.

Authors:  Shiyong Yu; Guohong Li
Journal:  J Cardiovasc Transl Res       Date:  2010-06       Impact factor: 4.132

4.  Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application.

Authors:  Xiaojun Liu; Yunhui Cheng; Jian Yang; Ling Xu; Chunxiang Zhang
Journal:  J Mol Cell Cardiol       Date:  2011-11-22       Impact factor: 5.000

Review 5.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

6.  Regulation of WNK1 expression by miR-192 and aldosterone.

Authors:  Emilie Elvira-Matelot; Xiao-ou Zhou; Nicolette Farman; Geneviève Beaurain; Alexandra Henrion-Caude; Juliette Hadchouel; Xavier Jeunemaitre
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

Review 7.  MicroRNA in ischemic stroke etiology and pathology.

Authors:  Cameron Rink; Savita Khanna
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

8.  MicroRNAs as new players in the genomic galaxy and disease puzzles.

Authors:  Elisa Barbarotto; Paola Secchiero; Abhijit Dasgupta; Paolo Fortina; George A Calin; Terry Hyslop
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

9.  Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension.

Authors:  J E Kontaraki; M E Marketou; E A Zacharis; F I Parthenakis; P E Vardas
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

Review 10.  Regulation of an inflammatory disease: Krüppel-like factors and atherosclerosis.

Authors:  Mukesh K Jain; Panjamaporn Sangwung; Anne Hamik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-13       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.